Martin Beck

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Ekosem-Agrar AG is a holding company, with interests in the the production and processing of animal and vegetable agricultural products. Its products includes diary and diary related products, agriculture, seed production and breeding, suckler cow husbandry and organic agriculture. The firm grows grain, potatoes, peas, sunflowers, sugar beets, soybeans, fodder, and other crops. The company was founded by Stefan Dürr in 1994 and is headquartered in Walldorf, Germany.

Ehrmann AG manufactures and distributes dairy products. It offers almighurt, grand dessert, orchard, dreams, lacto zero, and natural products. The company was founded by Alois Ehrmann in 1920 and is headquartered in Oberschönegg, Germany.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Pharma GmbH & Co., KG is a company that operates research-based pharmaceutical companies and serves. Boehringer Ingelheim Pharma GmbH & Co., KG is based in Ingelheim, Germany. The German company was founded in 1885 by Albert Boehringer. The CEO is Hubertus von Baumbach.

Boehringer Ingelheim Ltd. develops, manufactures, and distributes pharmaceutical products. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, Parkinson's disease, arthritis, and pain relief in cancer. The company was founded in 1885 and is headquartered in Bracknell, the United Kingdom.

Anasco GmbH is a company based in Ingelheim am Rhein, Germany. Part of C.H. Boehringer Sohn AG & Co. KG, Anasco GmbH provides investment services. The German company was founded in 1992, and the CEOs are Frank Hübler and Michael Schmelmer.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Europe GmbH is a German company that manufactures basic pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler and Martin Schwarz. The company was founded in 1990.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Vetmedica GmbH is a German company dedicated to the research and development of products related to animal health. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Dana Leskova, Stephan Günther Dolle.

Boehringer Ingelheim Middle East & Africa GmbH manufactures pharmaceutical products. The company is headquartered in Ingelheim am Rhein, Germany.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Finanzierungs GmbH is a financial services provider. The company is based in Ingelheim am Rhein, Germany. The CEOs are Jochen Gann, Martin Schwarz. The German company was founded in 1968.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Verwaltungs GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs are Andreas Neumann, Michael Schmelmer. The company was founded in 2007.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health Japan Holding GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Frank Hübler, Martin Schwarz.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Animal Health China Participations GmbH provides veterinary services. The company is based in Ingelheim am Rhein, Germany. The CEOs are Frank Hübler, Martin Schwarz. The German company was founded in 2019.

Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim.